The Kizi Apparels IPO is a closed SME Fixed Price offer (Fresh Capital) that opened on 30 July 2024. The Kizi Apparels IPO closed on 1 August 2024, with an issue price of ₹21 per share. The Kizi Apparels IPO has a face value of ₹10 and a lot size of 6,000 shares. The Kizi Apparels IPO is listed on 6 August 2025. The Kizi Apparels IPO allotment was scheduled for 2 August 2024.
On the financial front, the Kizi Apparels IPO reported revenue of ₹2,027 for 31 Mar 2024, compared with ₹1,550 for 31 Mar 2023. The Kizi Apparels IPO PAT was ₹72 against ₹55. The Kizi Apparels IPO net worth as of 31 Mar 2024 was ₹587.
Always verify The Kizi Apparels IPO details and GMP data with the official offer document before investing in the Kizi Apparels IPO.
Financial Summary
Amount in ₹ Lakhs
Metric
31 Mar 2024
31 Mar 2023
31 Mar 2022
Total Assets
1,340
1,135
725
Revenue
2,027
1,550
539
PAT
72
55
21
Net Worth
587
395
337
Reserves
71
—
—
Total Borrowing
515
311
243
Kizi Apparels IPO Financials FAQs
Revenue of Kizi Apparels (Amount in ₹ Lakhs) — 31 Mar 2024: 2,027; 31 Mar 2023: 1,550; 31 Mar 2022: 539. Profit after tax (PAT) — 31 Mar 2024: 72; 31 Mar 2023: 55; 31 Mar 2022: 21.
Total assets — 31 Mar 2024: 1,340; 31 Mar 2023: 1,135; 31 Mar 2022: 725. Net worth — 31 Mar 2024: 587; 31 Mar 2023: 395; 31 Mar 2022: 337. Reserves & surplus — 31 Mar 2024: 71. (Amount in ₹ Lakhs)
Total borrowing of Kizi Apparels (Amount in ₹ Lakhs) — 31 Mar 2024: 515; 31 Mar 2023: 311; 31 Mar 2022: 243. Debt-to-equity ratio: 0.88.
The financials shown for Kizi Apparels IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
